Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Frederike Fuhlbrück"'
Autor:
John F. Palma, Maureen Peterson, Yuqiu Jiang, Stephanie J. Yaung, Wei Zou, Namrata Patil, Frederike Fuhlbrück
Publikováno v:
JCO Precision Oncology. :1271-1279
PURPOSE Somatic mutations derived from the expansion of clonal populations of blood cells (clonal hematopoiesis of indeterminate potential, or CHIP) may be detected in sequencing of cell-free DNA (cfDNA) samples. We evaluated the potential implicatio
Autor:
Aarthi Balasubramanyam, Sebastian Froehler, Ralph Floegel, H. Jost Achenbach, Rainer Krügel, Alexander F. Lovejoy, Lijing Yao, Frederike Fuhlbrück, Li Tai Fang, Hans-Peter Adams, Nalin Tikoo, John Jiang, John F. Palma, Stephanie J. Yaung, Preeti Lal
Publikováno v:
The Journal of Molecular Diagnostics. 22:228-235
Molecular biomarkers hold promise for personalization of cancer treatment. However, a typical tumor biopsy may be difficult to acquire and may not capture genetic variations within or across tumors. Given these limitations, tumor genotyping using nex
Autor:
Stephanie J. Yaung, Wei Zou, Frederike Fuhlbrück, David R. Gandara, Marcus Ballinger, John F. Palma, Namrata Patil, David S. Shames, Yuqiu Jiang, Eric Peters
Publikováno v:
JCO precision oncology. 5
PURPOSE Identification of predictors for overall survival (OS) allows timely detection of clinical efficacy signals and therefore facilitates treatment decisions. We assessed the association between circulating tumor DNA (ctDNA) metrics and the prima
Autor:
Frederike Fuhlbrück, Jacklyn Casanova, Yun-Te Lin, Patricia Gonzales, Cleo Keppens, Tracy McMillen, Krupa Jani
Publikováno v:
The Journal of Molecular Diagnostics : JMD
Autor:
Namrata Patil, Maureen Peterson, David R. Gandara, Johnny Wu, Eric Peters, David S. Shames, Marcus Ballinger, Stephanie J. Yaung, Wei Zou, John Jiang, John F. Palma, Frederike Fuhlbrück
Publikováno v:
Annals of Oncology. 30:v642-v643
Background Overall survival (OS) is the most relevant endpoint for evaluation of checkpoint inhibitors (CPI). Identification of early surrogates of OS is important to inform early clinical efficacy signals and treatment decisions. Here, we evaluated
Autor:
Namrata Patil, Johnny Wu, John F. Palma, Stephanie J. Yaung, Frederike Fuhlbrück, Wei Zou, Maureen Peterson, Fergal Casey, Yuqiu Jiang
Publikováno v:
Journal of Clinical Oncology. 37:9050-9050
9050 Background: Somatic mutations derived from the expansion of clonal populations of blood cells (clonal hematopoiesis of indeterminate potential, or CHIP) may be detected in sequencing of cell-free DNA (cfDNA) samples. We evaluated the potential i
Autor:
Frank Marusch, Stephanie J. Yaung, Sylvie McNamara, Thomas Steinmüller, Preeti Lal, Rainer Kube, Michael Heise, Li Tai Fang, Matthias Pross, René Mantke, Sebastian Fröhler, John Lee, Frederike Fuhlbrück, A. Rosenthal, Corinna Wöstmann, Lijing Yao, John F. Palma, Hans-Peter Adams
Publikováno v:
Cancer Research. 78:2960-2960
Introduction: Determining mutations in plasma (cfDNA) is a noninvasive method of profiling tumor genomic alterations. In this study, concordance of SNVs using NGS between matched plasma and formalin-fixed, paraffin-embedded (FFPE) tissue samples was
Autor:
Frank Habermann, Evelin Wacker, Arthur Allignol, Frederike Fuhlbrück, Juliane Fritzsche, Corinna Weber-Schoendorfer, Christof Schaefer, Reinhard Meister
Publikováno v:
Journal of clinical psychopharmacology. 33(4)
Women of childbearing age are often affected with psychotic disorders, requiring the use of antipsychotic medication during pregnancy. In the present study, we prospectively followed the pregnancies of 561 women exposed to second-generation antipsych
Autor:
Frederike Fuhlbrück
Publikováno v:
Journal of Clinical Psychopharmacology. 34:326